Zoetis Profile

Performance

   

Odds of Distress

12%12%
Check how we calculate scores
Equity ratings for Zoetis are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 26, 2019 and ending today August 25, 2019. Click here to learn more.
123.07
USD 3.57  2.82%

Zoetis Summary

Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people. The company currently falls under 'Large-Cap' category with total capitalization of 60.53B. Zoetis runs under Healthcare sector within Drug Manufacturers - Specialty & Generic industry. The entity has 478.66M outstanding shares of which 3.95M shares are at this time shorted by investors with about 2.44 days to cover shorted positions. has about 1.78B in cash with 1.21B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.73.
Check Zoetis Probability Of Bankruptcy

Ownership Allocation (%)

Zoetis Target Price Odds Analysis

Odds Below 123.07HorizonTargetOdds Above 123.07
86.72%30 days 123.07 13.12%
Based on normal probability distribution, the odds of Zoetis to move above current price in 30 days from now is about 13.12% (This Zoetis probability density function shows the probability of Zoetis Stock to fall within a particular range of prices over 30 days) .

Zoetis Top Holders

Zoetis Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Zoetis Key Fundamentals

Zoetis Against Markets

Zoetis Vital Trading Data

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people. more
NameZoetis
CEO and DirectorJuan AlaixView All
Thematic Classification
Currently Active Investing Idea
  Obamacare Repeal
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address10 Sylvan Way
ExchangeBATS Exchange
CIK Number0001555280
ISINUS98978V1035
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
BenchmarkDOW
Websitewww.zoetis.com
Phone973 822 7000
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 31, 2019

Zoetis Distributions to stockholders

Zoetis Corporate Directors

William Steere Independent Director
Linda Rhodes Director
Frank DAmelio Director
See also Your Current Watchlist. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Search macroaxis.com